Introduction
Cancer is a major, worldwide, public health problem, and epidemiologic and animal studies have indicated that vegetables and fruits with chemopreventive natural products, alone or in mixtures, are associated with reducing the risk of developing cancer [1] [2] [3] . DNA polymerase (DNA-dependent DNA polymerase [pol] , E.C. 2.7.7.7) catalyzes deoxyribonucleotide addition to the 3'-hydroxyl terminus of primed double-stranded DNA molecules [4] . As pols play important maintenance roles in key eukaryotic systems, such as DNA replication, recombination and repair [5] , pol inhibitors can be employed as anticancer chemotherapy agents because they inhibit cell proliferation. Based on pol inhibitors' strategic effects, we have been screening for mammalian pol inhibitors from natural phytochemical products in vegetables and fruits for over 15 years.
The human genome encodes at least 15 DNA pols that conduct cellular DNA synthesis [6, 7] . Eukaryotic cells contain 3 replicative pols (ex, 8 and E), 1 mitochondrial pol (y), and at least 11 non-replicative pols (13, S, Yj, e, t, K, "A, fl, v, terminal deoxynucleotidyl transferase (TdT) and REVl) [8, 9] . Pols have a highly conserved structure, with their overall catalytic subunits showing little variance among species; conserved enzyme structures are usually preserved over' time because they perform important cellular functions that confer evolutionary advantages. On the basis of sequence homology, eukaryotic pols can be divided into four main families, termed A, B, X and Y [9] . Family A includes mitochondrial pol y as well as pols e and v; family B includes the three replicative pols ex, 8 and E, and also pol s; family X comprises pols 13, "A and fl as well as TdT; and last, family Y includes pols Yj, t and K in addition to REVI. The focus is on replicative pol inhibition as it supposes a concurrent antitumor effect because replicative pols, such as B-family pols, are essential for the cell division required for cancer cell growth. As a result of this laboratory's ongoing screening from natural materials and compounds, glycoglycerolipids from a fern and an alga have been identified that potently inhibit eukaryotic pol activities [10, 11] .
In higher plants, particularly in chloroplasts, the thylakoid membrane contains major glycoglycerolipids, such as monogalactosyl diacylglycerol (MGDG), digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol [12] . It is known that glycoglycerolipids are present in vegetables, fruits and grains [13, 14] , and it has been found here that spinach possesses the best glycoglycerolipid source, with the highest MGDG content, among the vegetables tested [15] .
Cytidine analogs, such as gemcitabine (GEM, 2',2'-difluoro-2'-deoxycytidine, dFdC) are widely used to treat a variety of cancers and remains in standard therapy for pancreatic cancer in adjuvant and palliative settings [16] [17] [18] . However, the GEM response rate is very low in pancreatic cancer, with only an 18% I-year survival rate [19] , which is attributed primarily to the lack of early detection and frequent metastases of primary tumors into lymph nodes and surrounding organs, such as liver and stomach [20] [21] [22] . In human cells, GEM must be metabolized by phosphorylation and catalyzed by deoxycytidine kinase to GEM-5'monophosphate (GEM-MP), which can subsequently be phosphorylated sequentially to the diand triphosphate forms, GEM-5'-diphosphate (GEM-DP) and GEM-5'-triphosphate (GEM-TP), respectively. Studies using LCIMSIMS have shown that GEM penetrates into cells and that clinically relevant levels of GEM was intracellularly phosphorylated for 24 h, with the converted GEMs, such as GEM-TP, pooling in the cells [23] .
In this study, we focused our attention on evaluating human various cancer cell proliferation effects caused by a combination of GEM ( (Fig. lC) . Furthermore, the most effective timing of addition of these compounds was examined. In light of the results, their implications are discussed in terms of the observed properties of GEM and MGDG based on mammalian replicative pol inhibition as well as better treatment outcomes for human pancreatic cancer. 
Materials and methods

Materials
GEM
Chemical synthesis of phosphorylated GEM
~-benzoylgemcitabine [24] was converted to ~-benzoylgemcitabine 5'-diphosphate and 5'-triphosphate by selective phosphorylation with phosphoryl chloride in triethyl phosphate [25] , followed by further phosphorylation using a phosphorimidazolidate method [26] . GEM-MP, GEM-DP and GEM-TP were obtained by treatment of the corresponding~ 
Pol assays
Mammalian pols with high activities were purified according to our previous report [27] , and standard pol reaction mixtures for pols a and 13 have been previously described [28] ;
those for pol y and for pols 8 was then measured in a microplate reader (Model 680, Bio-Rad Laboratories, Hercules, CA). Co.) and apoptotic cells quantitated as a percentage ofthe total number of cells.
Assessment of apoptotic cells
Results
Effects of GEM and phosphorylated GEMs on mammalian pol activities
Initially, GEM ( as representative of the B, X, A and Y families of pols, respectively [6] [7] [8] . Among these compounds, GEM-TP was the strongest inhibitor of these mammalian pols, while GEM had no effect (Fig. 2) . The inhibitory effect of these four compounds on mammalian pols was ranked as follows: GEM-TP> GEM-DP > GEM-MP > GEM; therefore, the degree of GEM phosphorylation appeared important for pol inhibition. The inhibitory effect of GEM-TP on the activities of pols a and y, which are DNA replicative pols in the nucleus and mitochondria, respectively, was stronger than that of pols ~ and K, which are DNA repair-related pols. Table   1 shows the 50% inhibitory concentrations (ICso's) of GEM-TP on the activities of 11 mammalian pols, showing a 4-fold stronger inhibition ofB-family pols than X and V-families of pols. It is interesting that GEM-TP is an effective inhibitor of DNA replicative pols, such as pols a, 6 and E, causing a 50% inhibition of these pols at 3.4-3.8 f.lM.
Effects of the purified spinach MGDG on the activities of mammalian pols
MGDG, a yellow oily material, was purified from dried spinach (Spinacia oleracea L.), and the chemical structure analyzed by nuclear magnetic resonance, mass spectroscopy, and optical rotation. Its structure was characterized ( Fig. lC) [12] , and the two acyl groups of MGDG found to be mainly palmitoleic acid (CI6:I) and a-linolenic acid (CI8:3).
The effects of the purified spinach MGDG on mammalian pols are shown in Table 1 .
This compound selectively inhibited the activities of calf pol a, and human pols y, 6 To confirm the pol a noncompetitive inhibitory mode against DNA template-primer substrate by GEM-TP and MGDG, their binding should be precisely analyzed by gel mobility shift assay as described previously [32] . Mammalian pol a is made up of four subunits, i.e. p180, p68, p54 and p46 [6, 33] . The largest subunit, p180, and the smallest subunit, p46, have the catalytic DNA polymerase and DNA primase activities, respectively. The other subunits, p68 and p54, have no known enzyme activities. We constructed the core domain (p 110) in which we deleted the amino-terminal (1-329) and the carboxyl-terminal (1280--1465) regions of the largest (p 180) subunit of mouse pol a, and then the recombinant proteins were expressed and purified [34] . The core domain of pol a protein (0.2 nmol) was bound to M13 single-stranded DNA (ssDNA, 2.2 nmol; nucleotide), such as DNA template-primer substrate, and were shifted in the gel. When the IIE ratio (the molecular ratios of inhibitor and enzyme) was 100, both GEM-TP and MGDG had no interfered with the complex formation between M13 ssDNA and pol a (Supplemental Fig. 2) . These results suggested that GEM-TP and MGDG did not compete with M13 ssDNA and had no interfered with the binding of DNA template-primer substrate to the largest subunit of pol a.
Inhibition by GEM-TP of mammalian pol activities with or without MGDG
As the pol a inhibitory mode of GEM-TP against nucleotide substrate was different from that of MGDG in kinetic analyses, the question of whether MGDG could enhance pol inhibition by GEM-TP was investigated. As described in Materials and methods, GEM-TP and MGDG were preincubated with the standard pol reaction mixtures containing DNA template-primer/nucleotide substrates and pol enzymes. The concentrations of GEM-TP and MGDG added were one half of the ICso for each pol and 20 )..lM, respectively. In this study, calf pol a, rat pol 13, human pol y and human pol K were used as representative of pol families ofB, X, A and Y, respectively.
The rate of pol relative activity by GEM-TP at one-half of the IC so value for each mammalian pol was set at 1 (pol relative activity of ~75%), and the ratios ofthe activities by MGDG alone and in combination with GEM-TP are shown in Fig. 3 . As 20 )..lM MGDG alone did not inhibit the activities of pols 13 and K, the rate of pol relative activity was 1.33 (this pol relative activity at 100%), and pols a and y were slightly inhibited. The combination of GEM-TP with MGDG significantly enhanced the inhibition of pols a and y, with the inhibitory effect for pol a 2-fold stronger than that for pol y. The effect of the GEM-TPIMGDG combinations on pols 13 and K activity was the almost same as with GEM-TP alone. These results suggested that mixtures of GEM-TP and MGDG showed synergistic effects on the inhibitory activity of DNA replicative pols, such as with pols a and y according to the differences in the mode of pol inhibition.
Effects of GEM, phosphorylated GEMs, and MGDG on cultured human cancer cells
As pols conduct cellular DNA synthesis [4] [5] [6] and are essential for DNA replication, repair, and subsequent cell division, inhibition of these enzymes will lead to cell death, particularly under proliferative conditions, such that pol inhibitors can be considered potential agents for cancer chemotherapy. GEM is clinically used in the treatment of various carcinomas and, in particular, possesses greater clinical benefit to pancreatic cancer patients compared with conventional medications [35] . Thus, the effect of OEM, phosphorylated
OEMs and MODO on the cultured cell growth was investigated in human various cancer cells, such as pancreatic carcinoma cell lines.
Here, OEM dose-dependently suppressed cell proliferation of three human pancreatic cancer cell lines, BXPC-3, MIAPaCa2 and PANC-I, with a 50% lethal dose (LDso) of 3.0, 15.1 and 17.6 nM, respectively ( Fig. 3A-3C ), suggesting that OEM's effect on BXPC-3 cell growth inhibition was the strongest among the three lines. OEM might have been able to penetrate these human cancer cells, undergo phosphorylation to OEM-TP, which then reached the nucleus, and inhibited pol activities, with the specific inhibition of DNA replicative pol activity leading to cell growth suppression. On the other hand, phosphorylated OEM, such as OEM-MP, OEM-DP and OEM-TP, had no effect on cancer cell growth, which suggested that these compounds did not penetrate the cells.
MODO also suppressed the growth of these human pancreatic cancer cell lines ( Fig. 40 and Table 2 ), suggesting that MODO penetrated human cancer cells and effectively inhibited nuclear and mitochondrial replicative pol activities. It was considered here that OEM penetrated into cells more effectively than MODO, as OEM exhibited a ~ 1 OOO-fold stronger toxicity than MODO.
Next, additional experiments were carried out on OEM and MODO in the latter part of this study. As shown in Table 3 , the influence of OEM on the growth of human other cancer cell lines, such as lung (A549), prostate (DUI45 and PC3), cervix (HeLa), hepatocellular liver (HepG2) and breast (MCF-7), and a human normal cell line, PHDFCs, was similar to that obtained for the pancreatic cancer cell lines. The LD50 values of MGDG for the three pancreatic cancer cell lines were> 1.6-fold higher than those for other cancer cell lines. In contrast, MGDG exhibited no effect toward PHDFCs; therefore, MGDG form spinach, which is a food component, could selectively inhibit human cancer cell growth.
Cell growth inhibition by combinations of GEM with MGDG of cultured human cancer cells
The cell growth suppression effects of combined GEM and MGDG treatments were therefore, these effects showed the same tendency in all three cell lines. In contrast, the enhancement of cell growth suppression by combination of GEM and MGDG was not shown against the other human cancer cell lines tested, because the cytotoxic rations of MGDG / schedule (c) (i.e., MGDG-GEM) were 0.94-1.47 (Table 4 ). These results suggested that the timing of the application of GEM and MGDG might be very important for the suppression of human pancreatic cancer cell proliferation in the use of clinical GEM-MGDG combination treatments.
Apoptosis induction in cultured human pancreatic cancer cells by combinations of GEM withMGDG
As MIAPaCa2 cells showed the highest synergistic effect from schedule (c) on cell growth suppression among the human pancreatic cancer cell lines tested (Fig. 4A-4C cells was normalized to 1, and treatment of both GEM alone and MGDG alone was found to slightly induce apoptosis ( Fig. 6 ). On the other hand, the present combination of GEM with MGDG significantly enhanced the appearance of apoptotic cells, suggesting that the synergistic effect on cell proliferation suppression may also induce apoptosis (Fig. SB(c) ).
The direct DNA fragmentation ofMIAPaCa2 cells was analyzed by electrophoresis, and these cells clearly underwent DNA fragmentation by GEM, MGDG and the combination of MGDG-GEM (Supplemental Fig. 3 ). It is thus considered that DNA damage in the cells was caused immediately with GEM treatment and that pol inhibition by phosphorylated GEM, such as GEM-TP and MGDG might have promoted apoptosis.
Discussion
Pancreatic cancer remains one of the most deadly and chemoresistant cancers.
Multiple studies have evaluated various chemotherapeutic agents, but few have produced significant improvement in patient survival [36] . GEM remains the first-line drug for the treatment of advanced pancreatic cancer, either alone or in combination with other chemotherapeutic agents, but the inherent resistance of pancreatic cancer to currently available chemotherapeutic agents presents a major challenge [36] [37] [38] . Identification of robust new molecular targets and relevant pathways to produce greater sensitivity to chemotherapeutic agents is a top priority [36] . Several mechanisms, involving factors such as STAT3 and NF-KB, have been reported to induce GEM resistance in preclinical models [39, 40] . However, clinically, only one study has reported a survival improvement, of <2 weeks, with a combination of erlotinib and GEM [41] , which highlights the urgent need to find novel agents against relevant molecular targets to produce new, more effective treatments.
In this study, the focus was on DNA replicative pol species, especially the B-family pol ex among 15 mammalian pols, as a new, metabolically critical molecular target to GEM treatment for human pancreatic cancer.
GEM is a nucleoside analog of dCTP, in which the hydrogen atoms on the 2' carbon of deoxycytidine are replaced by fluorine atoms (Fig. lA) , and can replace dCTP, one of the building blocks of nucleic acids during DNA replication by pols. Thus, the inhibitory mode of GEM-TP for pol ex, a DNA replicative pol, was predictably competitive with the nucleotide substrate ( Table 2 ). In the cells tested, GEM was enzymatically phosphorylated, such as to GEM-TP, and then arrested cell growth ( Fig. 4A-4C ), as only one additional nucleoside could be attached to the "faulty" nucleoside, resulting in cytotoxicity of both normal and cancer cells ( Table 3 ) and induction of apoptosis (Fig .6 ).
MGDG is a glycoglycerolipid non-nutrient compound found in vegetables, grains and fruits and, although its content varies among these plants [42] , it is ingested daily in food.
MGDG's chemical structure includes two acyl groups derived from two fatty acid molecules ( Fig. 1) . Wheat flour MGDG includes non-n-3 fatty acids, such as n-6 linoleic acid and saturated fatty acids [43] , and the fatty acyl component appears to influence MGDG's antitumor effects. Therefore, the present findings suggested that researchers should observe and pay close attention to the lipid content and inherent fatty acid composition in MGDG studies.
In this study, MGDG, isolated from spinach (Spinacia oleracea L.), was found to a selective inhibitor of mammalian pols ex, y, 8 and E, while having no effect on other mammalian pols, such as repair-related pols f3, Yj, t, K, A, /J. and TdT ( Table 1 ). The mechanism of selective inhibition between A and B-families pols, which are DNA replicative pols, and X and Y-families of pols, which are DNA repair-related pols, by MGDG remains unclear and will require further study. This spinach MGDG prevented cell growth in three cancer cell lines ( Fig. 4D) and, as the MGDG LD50'S on cell growth were almost the same of MGDG's IC50'S on pol activities, this inhibition was concluded to be mostly caused by direct effects on pol functions. MGDG appeared to be able to penetrate cancer cells and reach the nucleus and mitochondria, thus inhibiting mammalian pol ex, y, 8 and E activities and leading to cell growth suppression. It may be considered that the expression amounts and activities of pols ex, 8 and E, all nuclear DNA replicative pols, as well as pol y, a mitochondrial DNA replicative pol, in cancer cells are high and, thus, MGDG could inhibit various cancer cell proliferation, but did not influence normal cell growth ( Table 3) .
The present study is the initial investigation into the effects of combinations of GEM with MGDG, the latter a selective mammalian pol inhibitor. The results of this study indicated that GEMIMGDG enhanced the growth suppression of cells based on the inhibition of pol activities ( Fig. 5A ] showed significantly greater anticancer effects, such as inductions of cell death and apoptosis, than other combined GEM and MGDG treatments in human pancreatic cancer cells ( Fig. 5 and Table 4 ). It is not clear at this moment why MGDG-treated cells followed by GEM addition (i.e., MGDG.-GEM) significantly enhanced cell proliferation suppression in human pancreatic cancer cell lines, but had no affected on the enhancement in the other human cancer cell lines; therefore, we will consider them more stringently in future studies. These results indicated that combining selective inhibitors of mammalian pols, such as MGDG and GEM, might have clinical potential in a pancreatic cancer treatment strategy.
In conclusion, the present findings suggest that an anticancer mechanism in which GEM easily enters and is quickly phosphorylated to GEM-TP within human pancreatic cancer cells and subsequently suppresses cell proliferation based on pol inhibition. Spinach MGDG was found to selectively inhibit the activities of mammalian DNA replicative pols. In particular, MGDG's inhibitory activity against pol ex was different from that ofGEM-TP and, therefore, might further enhance the chemotherapeutic potential of GEM against pancreatic cancer. Spinach MGDG could be a functional food for anticancer regimes without side effects. Normal cells PfiHbDbFICS (prlilm)ary human dermal 5.0 ± 0.6 > 100 I ro astce s The 9 human cancer cell lines and a normal human cell line, PHDFCs, were incubated with each compound for 48 h. Cell viability was determined using the MTT assay; data, mean ±SD (n=5).
Table 4
Effect of the combinations of GEM and MGDG on cell growth suppression against cultured human cancer cell lines (1) > 0.8 ·z ro (1) .... 
